Analysis from continued follow-up of Phase 1/2 clinical trial data in Hunter syndrome (MPS II) reinforces potential for tividenofusp alfa (DNL310) to address full disease spectrumLaunch readiness ...

Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...

BrainIAC is an innovative AI foundation model developed by Mass General Brigham that was trained on nearly 49,000 brain MRI ...

Interpretation is the discipline through which molecular datasets reveal their significance. As the life sciences enter a new era defined by data richness and technological capacity, interpretive ...

New retrospective analysis showed Orca-T with reduced intensity conditioning (RIC) demonstrated favorable OS, RFS and GRFS compared to PTCyCompany announced first patients dosed in the Phase 2 ...

New research suggests that statins, effective cholesterol-lowering drugs, don't cause many of the side effects listed on ...

Metastasis-directed therapy (MDT) significantly improved outcomes in patients with oligometastatic prostate cancer, according ...

Biotech data visualization is often static and fragmented, limiting the ability to see integrated patient journeys and ...

Viking Therapeutics, Inc. aces hurdles for obesity drug VK2735 vs. Zepbound/Wegovy—tolerability, weak differentiation, and ...

A string of clinical and regulatory milestones in the December quarter highlighted growing momentum for ASX health stocks ...

New data challenge common beliefs about antihistamines, corticosteroids, and vaccines in chronic urticaria, with practical ...

LCGC International salutes Jack Henion and Bob W.J. Pirok, winners of the 19th annual LCGC Lifetime Achievement and Emerging ...